Board Of Directors

Mazor Robotics’ Board of Directors consists of well-known leaders from the finance, medical and technical sectors. These diverse voices lend layers of expertise that help shape and guide in the development and innovation of Mazor Robotics’ technologies. Read the bios below to learn more about each member.

 
Jonathan Adereth
Jonathan AderethChairman of the Board
Mr. Adereth has been serving as the chairman of Mazor's Board of Directors since December 2007. Since May 2009, Mr. Adereth has also been serving as the chairman of Medic Vision Imaging Solutions Ltd. (an Israeli company) in the field of dose reduction in computed tomography. Since October 2004, Mr. Adereth has been serving as a board member of UltraSPECT Ltd. (an Israeli company) in the field of dose reduction in nuclear medicine. Since February 2012, Mr. Adereth has been serving as a director and later, as a chairman of UCCare Ltd. (an Israeli company) in the field of prostate cancer detection and treatment. From 1994 to 1998, Mr. Adereth served as the Chief Executive Officer and President of Elscint Ltd. (NYSE: ELT), a global developer and manufacturer of CT and MRI systems. Mr. Adereth holds a B.Sc. degree in Physics from the Technion - Israel Institute of Technology.
Ori Hadomi
Ori HadomiCEO of Mazor Robotics, Director
Mr. Hadomi brings years of valuable medical technology experience to Mazor Robotics. A seasoned financial and business leader, Mr. Hadomi was previously the CFO and VP of Business Development at DenX, an image-guided dental surgery company. He was also the Founder and CEO of a motion tracker for medical applications called 7D Ltd., and Chairman of the Izmel Scientific committee, which is a consortium for the image-guided industry. .
Sarit Soccary Ben-Yochanan
Sarit Soccary Ben-YochananDirector
Sarit Soccary Ben-Yochanan brings to Mazor extensive financial and business management experience in developing successful companies. Before Ms. Soccary has been serving as a director in the Company since October 2006. Since July 2013, Ms. Soccary has been serving as the Vice President of Strategy and Business Development for Syneron Medical Ltd. (NASDAQ: ELOS). Until July 2013, Ms. Soccary had been serving as the Chief Executive Officer of Gefen Biomed Investments Ltd., an Israeli public company. Ms. Soccary also served as a Director of Proteologics Ltd., an Israeli public biotech company, and as a director of several private companies in the fields of technology and healthcare. Ms. Soccary holds a B.A. and an M.A. in economics from Tel Aviv University.
Michael Berman
Michael BermanDirector
Mr. Berman has been serving as a Director in the company since February 2014. Mr. Berman is a medical device entrepreneur and investor. He is a co-founder of eight medical device companies and is currently an active board member of several early stage health care companies. Additionally, he was a co-founder of Velocimed and BridgePoint Medical, as well as a board member of Lutonix and Ultrashape Inc. From 1995 to 2000, Mr. Berman was President of the cardiology business of Boston Scientific. Mr. Berman received his BS and MBA degrees from Cornell University.
Yuval Yanai
Yuval YanaiExternal Director
Mr. Yanai serves as an external director of Macrocure Ltd. and Check-Cap Ltd., Israeli companies whose shares are listed on the NASDAQ Global Market. Mr. Yanai also serves as an external director of Medical Compression Systems (D.B.N) Ltd. and as a director in Clal Biotechnology, Israeli companies whose shares are listed on the Tel Aviv Stock Exchange. Mr. Yanai also serves as an external director of Haddasah Medical Center, as an external director of Standard & Poors Maalot and as a director of Compulab Ltd. and Efranat Ltd. Mr. Yanai also acts as the Chairman of Endobetix Ltd. and the Israeli Fund for UNICEF. From September 2005 until March 2014, Mr. Yanai has served as Given Imaging’s Chief Financial Officer and from October 2012 until June 2014, Mr. Yanai has served as a director of Citycon Oyj. Mr. Yanai holds a B.Sc. degree in Accounting and Economics from Tel-Aviv University.
Gil Bianco
Gil BiancoExternal Director
Mr. Bianco has been serving as an external director since 2007. From 2001 to 2003, he served as chief executive officer to pharmaceutical manufacturer, Agis Industries Ltd., most notably taking part in the company’s listing on the TASE and its global expansion. Mr. Bianco is serving as a director of Fischer pharmaceuticals ltd, IntekPharma Ltd., Clear Cut Ltd., Gil Bianco Ltd., and Turquoise GEI Ltd. In the past five years, he also served as a director of Healor Ltd., Solgel Technologies Ltd., BioKansel Inc., Top Spin Ltd., Kolbar Ltd., BioLineRx Ltd., DPharm Ltd., Optima Ltd., and the Tel Aviv Stock Exchange Ltd. Mr. Bianco holds a B.A. in Economics and Accounting from the Tel Aviv University, and is a certified public accountant.

Latest News

19
Jul2017

Mazor Robotics to Report Second...

Conference Call Scheduled for 8:30am EDT on Tuesday, August 1st CAESAREA, Israel, July 19, 2017 – Mazor...

06
Jul2017

Mazor Robotics Received 19 System...

CAESAREA, Israel--(BUSINESS WIRE (http://www.businesswire.com/))-- Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a pioneer and a leader in the...

21
Jun2017

Mazor Robotics Ltd. Expands Leadership...

Caesarea, Israel – June 19, 2017 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and...

07
Jun2017

Mazor Robotics to Present at...

Caesarea, Israel - Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR (/index.php/investors-relations/mazor-stock-information)), a pioneer and leader in the...

18
May2017

Houston Methodist Hospital Adds the...

ORLANDO, FL and HOUSTON, TX – May 18, 2017 – Mazor Robotics, a pioneer and leader in...

17
May2017

Mazor Robotics Congratulates Surgeon for...

Orlando, Florida- April 12, 2017 – Mazor Robotics. a pioneer and leader in the field of surgical...

20
Apr2017

Mazor Robotics to Report First...

Conference Call Scheduled for 8:30am ET on Wednesday, May 10th CAESAREA, Israel–(BUSINESS WIRE (http://www.businesswire.com/))– Mazor Robotics Ltd. (TASE:MZOR;...

12
Apr2017

Mazor Robotics Receives FDA Clearance...

CAESAREA, Israel – April 12, 2017 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and...

05
Apr2017

Mazor Robotics Expects to Report...

CAESAREA, Israel–(BUSINESS WIRE)– Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the...

13
Mar2017

Mazor Robotics to Present at...

CAESAREA, Israel–(BUSINESS WIRE)– Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a leading developer of innovative bone mounted...

«
»

Latest Tweet


Dr. Ronald Lehman Jr. is 1st to use Mazor X™ Surgical Assurance Platform in NYC: https://t.co/FvAqs10SMx
Follow Mazor Robotics on Twitter